Anthropometric Parameters and the Incidence of Atrial Fibrillation in Older People: the PRO.V.A Study

Overview

Journal Clin Cardiol

Specialty Cardiology & Vascular Diseases

Date 2017 Feb 14

PMID 28191907

Citations 4

Authors

Caterina Trevisan

Stefania Maggi

Chiara Curreri

Giovanni Nante

Marianna Noale

Marina De Rui

Egle Perissinotto

Leonardo Sartori

Sabina Zambon

Gaetano Crepaldi

Enzo Manzato

Giuseppe Sergi

Affiliations

Soon will be listed here.

Abstract

Background: Atrial fibrillation (AF) has been associated with body size and central obesity, but the impact of different anthropometric measures in this relationship has been inadequately investigated.

Hypothesis: In this study, we examined the association between baseline anthropometric parameters with the incidence of AF in older people, hypothesizing that body size could impact the onset of AF more than fat distribution.

Methods: Our study included 1764 participants with a mean age of 74.3 ± 6.9 years and no AF at baseline. Body mass index (BMI), body height, body surface area (BSA), waist and hip circumference, waist-to-stature ratio, waist-to-hip ratio, and mid-upper arm circumference (MUAC) were measured by trained physicians. AF was assessed after a 4.4-year follow-up.

Results: There were 115 new cases of AF observed after the follow-up. Taking lower values of these measures for reference, the adjusted AF risk was 2.42 (95% confidence interval [CI]:1.88-3.12) for the highest stature quartile, 1.36 (95% CI:1.15-1.62) for BMI ≥30 kg/m , 2.12 (95% CI:1.73-2.59) for the highest BSA quartile, 1.38 (95% CI: 1.21-1.56) for higher MUAC, and 1.39 (95% CI: 1.23-1.58, P < 0.0001) for higher hip circumference values. Central obesity did not seem to relevantly predict the onset of AF in our sample. Stature revealed the strongest impact on the onset of AF (5% higher risk of developing AF per 1 cm increase in height).

Conclusions: Body size, particularly tall stature and obesity, but not fat distribution, seems to be associated with the risk of AF in the elderly.

Citing Articles

Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion.

Ligero C, Bazan V, Guerra J, Rodriguez-Manero M, Vinolas X, Alegret J PLoS One. 2023; 18(9):e0291938.

PMID: 37738256 PMC: 10516430. DOI: 10.1371/journal.pone.0291938.

Adult height and incidence of atrial fibrillation and heart failure in older men: The British Regional Heart Study.

Wannamethee S, Papacosta O, Lennon L, Hingorani A, Whincup P Int J Cardiol Heart Vasc. 2021; 35:100835.

PMID: 34286063 PMC: 8274296. DOI: 10.1016/j.ijcha.2021.100835.

Weight, height, weight change, and risk of incident atrial fibrillation in middle-aged men and women.

Johansson C, Lind M, Eriksson M, Johansson L J Arrhythm. 2020; 36(6):974-981.

PMID: 33335612 PMC: 7733566. DOI: 10.1002/joa3.12409.

Anthropometric parameters and the incidence of atrial fibrillation in older people: the PRO.V.A study.

Trevisan C, Maggi S, Curreri C, Nante G, Noale M, De Rui M Clin Cardiol. 2017; 40(7):461-468.

PMID: 28191907 PMC: 6490338. DOI: 10.1002/clc.22677.

References

Rosengren A, Hauptman P, Lappas G, Olsson L, Wilhelmsen L, Swedberg K . Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J. 2009; 30(9):1113-20. DOI: 10.1093/eurheartj/ehp076. View

Seidell J, Kahn H, Williamson D, Lissner L, Valdez R . Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr. 2000; 73(1):123-6. DOI: 10.1093/ajcn/73.1.123. View

Hanna I, Heeke B, Bush H, Brosius L, King-Hageman D, Beshai J . The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006; 47(8):1683-8. DOI: 10.1016/j.jacc.2005.11.068. View

Vincent H, Powers S, Stewart D, Shanely R, Demirel H, Naito H . Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord. 1999; 23(1):67-74. DOI: 10.1038/sj.ijo.0800761. View

Benjamin E, Levy D, Vaziri S, DAgostino R, Belanger A, Wolf P . Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271(11):840-4. View

Lauer M, Anderson K, Kannel W, Levy D . The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 1991; 266(2):231-6. View

Wanahita N, Messerli F, Bangalore S, Gami A, Somers V, Steinberg J . Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J. 2008; 155(2):310-5. DOI: 10.1016/j.ahj.2007.10.004. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32 Suppl 1:S62-7. PMC: 2613584. DOI: 10.2337/dc09-S062. View

Nystrom P, Carlsson A, Leander K, de Faire U, Hellenius M, Gigante B . Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One. 2015; 10(5):e0127111. PMC: 4433194. DOI: 10.1371/journal.pone.0127111. View

10.

Bella J, Devereux R, Roman M, OGrady M, Welty T, Lee E . Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation. 1998; 98(23):2538-44. DOI: 10.1161/01.cir.98.23.2538. View

11.

Heeringa J, van der Kuip D, Hofman A, Kors J, van Herpen G, Stricker B . Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006; 27(8):949-53. DOI: 10.1093/eurheartj/ehi825. View

12.

Corti M, Guralnik J, Sartori L, Baggio G, Manzato E, Pezzotti P . The effect of cardiovascular and osteoarticular diseases on disability in older Italian men and women: rationale, design, and sample characteristics of the Progetto Veneto Anziani (PRO.V.A.) study. J Am Geriatr Soc. 2002; 50(9):1535-40. DOI: 10.1046/j.1532-5415.2002.50409.x. View

13.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

14.

Desai N, Giugliano R . Can we predict outcomes in atrial fibrillation?. Clin Cardiol. 2012; 35 Suppl 1:10-4. PMC: 6652364. DOI: 10.1002/clc.20989. View

15.

Verdecchia P, Dagenais G, Healey J, Gao P, Dans A, Chazova I . Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE.... J Hypertens. 2012; 30(5):1004-14. DOI: 10.1097/HJH.0b013e3283522a51. View

16.

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S . Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213-20. PMC: 4064952. DOI: 10.2147/CLEP.S47385. View

17.

Frost L, Hune L, Vestergaard P . Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005; 118(5):489-95. DOI: 10.1016/j.amjmed.2005.01.031. View

18.

Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden D, Sasaki S . Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008; 117(10):1255-60. PMC: 2637133. DOI: 10.1161/CIRCULATIONAHA.107.744466. View

19.

Schmidt M, Botker H, Pedersen L, Sorensen H . Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol. 2013; 29(2):111-8. DOI: 10.1007/s10654-013-9867-y. View

20.

Gudbjartsson D, Arnar D, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A . Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007; 448(7151):353-7. DOI: 10.1038/nature06007. View